Effect and Predictive Elements for 52 Weeks’ Telbivudine Treatment on Naïve HBeAg positive Chronic Hepatitis B

BACKGROUND: Antiviral treatment with nucleoside analogs has been used for chronic hepatitis B (CHB). Each kind of nucleoside analog has its own characteristics and suitability for patients. Telbivudine (LdT, brand name: Sebivo, Beijing Novartis Pharma Ltd) is the newest nucleoside analog, with stron...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiao-Feng, Lu, Li-Xia, Wang, Ying, Xu, Kong-wen, Li, Da-jiang, Zhu, Xia, Liu, Li, Liu, Cong, Wang, Jin-Rong, Tang, Hong, Wang, Li-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282031/
https://www.ncbi.nlm.nih.gov/pubmed/22368682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282031/
https://www.ncbi.nlm.nih.gov/pubmed/22368682

Ejemplares similares